Detection of Cytokeratins in Normaland Malignant Laryngeal Epithelia by Means of Reverse Transcriptase-Polymerase Chain Reaction

Cytokeratins (CKs) are a subgroup of intermediate filament proteins that take part in forming the cytoskeleton. The epithelial cells in different organs express distinct CKs, and this expression may be modified during malignant transformation. Here we describe the use of reverse transcriptase–polyme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of otology, rhinology & laryngology rhinology & laryngology, 2002-02, Vol.111 (2), p.149-154
Hauptverfasser: Lahat, Nitza, Resnick, Murray B., Cohen-Kerem, Raanan, Elmalah, Irit, Doweck, Ilana, Greenberg, Elhanan, Rahat, Michal A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cytokeratins (CKs) are a subgroup of intermediate filament proteins that take part in forming the cytoskeleton. The epithelial cells in different organs express distinct CKs, and this expression may be modified during malignant transformation. Here we describe the use of reverse transcriptase–polymerase chain reaction followed by Southern blotting to determine the profile of expression of CKs in both normal and malignant laryngeal samples. Thirty-six samples were subjected to histologic examination and classified as 17 squamous cell carcinomas, 3 dysplastic lesions, and 16 normal samples. CK8 and CK 19 were expressed in almost all samples, both cancerous and normal, and were therefore used to verify the integrity of RNA. Expression of CK2, CK9, and CK20 was not detected in any of the samples, normal or cancerous. CK 15 and CK 18 showed low sensitivity for detection of cancer (36.4% and 45.5%, respectively). CK 10 showed relatively high sensitivity (91%), but only moderate specificity (69.2%). Only CK 17 showed both high sensitivity and specificity (91% and 92.3%, respectively; positive predictive value, 91%). We propose that CK17 may be considered a promising candidate to use as a molecular marker for malignant transformation in laryngeal squamous cell carcinoma.
ISSN:0003-4894
1943-572X
DOI:10.1177/000348940211100207